Geron Corporation Grants Stock Option to New Executive Vice President Timothy Williams

Stock Option Grant to New Executive Geron Corporation granted a stock option to purchase 2,500,000 shares of its common stock to Timothy Williams on April 13, 2026.

The grant served as an inducement material to Williams's acceptance of employment with the company. Geron Corporation is a commercial stage biopharmaceutical company. Williams accepted the position of Executive Vice President, Chief Legal Officer, and Corporate Secretary.

73 per share. This price equals the closing price of Geron Corporation's common stock on April 13, 2026. Geron Corporation's stock trades on NASDAQ under the ticker GERN.

Company Background Geron Corporation operates as a commercial stage biopharmaceutical company.

The company issued the stock option details via its official announcement. Benzinga reported on the employment and compensation arrangement. The grant occurred one day before the current date of April 14, 2026.

No additional details on Williams's prior experience appear in the available facts.

Employment Details Timothy Williams's acceptance of employment followed the stock option grant.

The role encompasses responsibilities as Executive Vice President, Chief Legal Officer, and Corporate Secretary. The inducement structure ties the compensation directly to his decision to join Geron Corporation. The exercise price alignment with the closing stock price on the grant date provides the valuation basis for the option.

Geron Corporation confirmed all elements of the arrangement in its statement.